New UTI Test Delivers Same-Day Results With 97% Accuracy

Why Waiting Days for UTI Treatment Is About to Become History

If you've ever suffered through a urinary tract infection, you know the absolute nightmare of waiting days for lab results while your doctor guesses which antibiotic might work. According to research published March 31 in the Journal of Antimicrobial Chemotherapy, those agonizing waits could soon be over thanks to a breakthrough UTI test that delivers results in under six hours with nearly 97% accuracy.

Scientists at the University of Reading, working alongside researchers from the University of Southampton and Hampshire Hospitals NHS Foundation Trust, have developed a revolutionary method that analyzes urine samples directly without the usual overnight culturing process. This means doctors can identify the correct antibiotic for your infection the same day you visit the clinic, rather than making you suffer through two or three days of uncertainty.

The numbers behind this breakthrough are seriously impressive. In trials involving 352 urine samples from patients suspected of having UTIs, the new UTI test matched standard laboratory methods in 96.95% of cases across seven first-line antibiotics. Even better, the test works fast—delivering results in about 5.85 hours on average compared to the current two to three day wait time that leaves patients in misery.

How This Rapid UTI Test Actually Works

The technology behind this medical innovation is surprisingly straightforward. A small cartridge containing tubes preloaded with different antibiotics gets placed directly into your urine sample and inserted into an analysis instrument. The system then uses optical imaging to monitor bacterial growth in each tube in real-time. If bacteria stop growing in a particular tube, that antibiotic is effective against your infection. If growth continues, that drug won't work for you.

Dr. Oliver Hancox, CEO of Astratus Limited—the University of Reading spin-out company bringing this UTI test to market—explained why same-day results matter so much for patient outcomes. "By the time the laboratory delivers the result under current methods, a patient may already have finished their antibiotics, or been given ones that do not work," he said. "Being able to tell a doctor the same day which antibiotic to use means the patient gets the right treatment sooner, reducing the risk of resistance developing and their infection turning into potentially lethal sepsis."

The implications extend far beyond individual patient comfort. NHS data reveals that urinary tract infections have caused more than 800,000 hospital admissions in England alone over the past five years. Even more concerning, approximately one in four urine samples tested in NHS laboratories contains bacteria resistant to commonly used antibiotics. With around 65 million urine samples analyzed annually in the UK, the potential impact of faster, more accurate UTI testing is absolutely massive.

Professor Mike Lewis, NIHR Scientific Director for Innovation, highlighted how this innovation addresses two critical healthcare challenges simultaneously. "This NIHR-funded research not only has the potential to deliver quicker, more effective treatments to patients suffering with UTIs—but also tackles the broader challenge of antimicrobial resistance," he stated. "The rapid urine test is a fantastic example of the real-world solutions to AMR that the government committed to developing in its 10-Year Health Plan."

What makes this study particularly significant is that researchers also tested whether adding preservative to samples would affect accuracy. By comparing 90 fresh samples collected with and without boric acid preservative, they found 98.75% agreement between results. This marks the first study to directly compare preserved and unpreserved urine samples using a rapid direct-from-urine testing method, confirming the UTI test works reliably regardless of storage conditions.

For Gen Z patients who have grown up expecting instant results in every aspect of life, this medical advancement feels long overdue. Professor Matthew Inada-Kim, a consultant acute physician and AMR Lead at Hampshire Hospitals NHS Foundation Trust, emphasized the practical benefits. "UTIs are a common reason that patients need antibiotics, and getting the right treatment first time could be a lifesaver," he noted. "A test that works on samples we already collect as standard, and gives us answers the same day, is exactly the kind of tool that could change how we manage these infections in practice."

While the technology is still making its way through commercialization via Astratus Limited, which was established in November 2024 specifically to bring this UTI test to market, the research foundation is solid and the clinical benefits are clear. For millions of people who experience the burning urgency of urinary tract infections each year, the future of healthcare just got a whole lot faster and more precise.